{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:44:20Z","timestamp":1768013060326,"version":"3.49.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s10067-025-07311-4","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T18:38:14Z","timestamp":1739299094000},"page":"1549-1569","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploring the molecular mechanism of Tripterygium Wilfordii Hook F in treating systemic lupus erythematosus via network pharmacology and molecular docking"],"prefix":"10.1007","volume":"44","author":[{"given":"Yanggang","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengrong","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7957-6106","authenticated-orcid":false,"given":"Chunyan","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"7311_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/ard-2022-223035","volume":"82","author":"J Tian","year":"2023","unstructured":"Tian J, Zhang D, Yao X et al (2023) Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis 82:351\u2013356. https:\/\/doi.org\/10.1136\/ard-2022-223035","journal-title":"Ann Rheum Dis"},{"key":"7311_CR2","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/s0140-6736(19)30237-5","volume":"393","author":"L Durcan","year":"2019","unstructured":"Durcan L, O\u2019Dwyer T, Petri M (2019) Management strategies and future directions for systemic lupus erythematosus in adults. Lancet 393:2332\u20132343. https:\/\/doi.org\/10.1016\/s0140-6736(19)30237-5","journal-title":"Lancet"},{"key":"7311_CR3","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1039\/d0np00054j","volume":"38","author":"L Tong","year":"2021","unstructured":"Tong L, Zhao Q, Datan E et al (2021) Triptolide: reflections on two decades of research and prospects for the future. Nat Prod Rep 38:843\u2013860. https:\/\/doi.org\/10.1039\/d0np00054j","journal-title":"Nat Prod Rep"},{"key":"7311_CR4","first-page":"827","volume":"94","author":"W Qin","year":"1981","unstructured":"Qin W, Wanzhang Q, Chenghuang L et al (1981) Tripterygium wilfordii Hook F in systemic lupus erythematosus: report of 103 cases. Chin Med J (Engl) 94:827\u2013834","journal-title":"Chin Med J (Engl)"},{"key":"7311_CR5","first-page":"317","volume":"99","author":"ZG Gao","year":"1986","unstructured":"Gao ZG, Zang AC, Bai RX (1986) Radix Tripterygium wilfordii Hook F in rheumatoid arthritis, ankylosing spondylitis and juvenile rheumatoid arthritis. Chin Med J (Engl) 99:317\u2013320","journal-title":"Chin Med J (Engl)"},{"key":"7311_CR6","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1159\/000452591","volume":"41","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Hong Y, Huang H (2016) Triptolide Attenuates inflammatory response in membranous glomerulo-nephritis rat via downregulation of NF-\u03baB Signaling Pathway. Kidney Blood Press Res 41:901\u2013910. https:\/\/doi.org\/10.1159\/000452591","journal-title":"Kidney Blood Press Res"},{"key":"7311_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.intimp.2013.04.018","volume":"16","author":"Y Li","year":"2013","unstructured":"Li Y, Tian Y, Zhu W et al (2013) Triptolide induces suppressor of cytokine signaling-3 expression and promotes lamina propria mononuclear cells apoptosis in Crohn\u2019s colitis. Int Immunopharmacol 16:268\u2013274. https:\/\/doi.org\/10.1016\/j.intimp.2013.04.018","journal-title":"Int Immunopharmacol"},{"key":"7311_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bbrc.2017.02.021","volume":"485","author":"R Li","year":"2017","unstructured":"Li R, Lu K, Wang Y et al (2017) Triptolide attenuates pressure overload-induced myocardial remodeling in mice via the inhibition of NLRP3 inflammasome expression. Biochem Biophys Res Commun 485:69\u201375. https:\/\/doi.org\/10.1016\/j.bbrc.2017.02.021","journal-title":"Biochem Biophys Res Commun"},{"key":"7311_CR9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/circresaha.119.315861","volume":"126","author":"S Ye","year":"2020","unstructured":"Ye S, Luo W, Khan ZA et al (2020) Celastrol attenuates angiotensin II-Induced cardiac remodeling by targeting STAT3. Circ Res 126:1007\u20131023. https:\/\/doi.org\/10.1161\/circresaha.119.315861","journal-title":"Circ Res"},{"key":"7311_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114177","volume":"158","author":"JL Tan","year":"2023","unstructured":"Tan JL, Yi J, Cao XY et al (2023) Celastrol: the new dawn in the treatment of vascular remodeling diseases. Biomed Pharmacother 158:114177. https:\/\/doi.org\/10.1016\/j.biopha.2022.114177","journal-title":"Biomed Pharmacother"},{"key":"7311_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.freeradbiomed.2022.06.009","volume":"188","author":"J Lu","year":"2022","unstructured":"Lu J, Zhang Y, Dong H et al (2022) New mechanism of nephrotoxicity of triptolide: oxidative stress promotes cGAS-STING signaling pathway. Free Radic Biol Med 188:26\u201334. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.06.009","journal-title":"Free Radic Biol Med"},{"key":"7311_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","volume":"43","author":"C Nogales","year":"2022","unstructured":"Nogales C, Mamdouh ZM, List M et al (2022) Network pharmacology: curing causal mechanisms instead of treating symptoms. Trends Pharmacol Sci 43:136\u2013150. https:\/\/doi.org\/10.1016\/j.tips.2021.11.004","journal-title":"Trends Pharmacol Sci"},{"key":"7311_CR13","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/nbt1007-1110","volume":"25","author":"AL Hopkins","year":"2007","unstructured":"Hopkins AL (2007) Network pharmacology. Nat Biotechnol 25:1110\u20131111. https:\/\/doi.org\/10.1038\/nbt1007-1110","journal-title":"Nat Biotechnol"},{"key":"7311_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116306","volume":"309","author":"L Zhao","year":"2023","unstructured":"Zhao L, Zhang H, Li N et al (2023) Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. J Ethnopharmacol 309:116306. https:\/\/doi.org\/10.1016\/j.jep.2023.116306","journal-title":"J Ethnopharmacol"},{"key":"7311_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2024.108749","volume":"130","author":"Y Hong","year":"2024","unstructured":"Hong Y, Wang Y, Wang D et al (2024) Assessing male reproductive toxicity of environmental pollutant di-ethylhexyl phthalate with network toxicology and molecular docking strategy. Reprod Toxicol 130:108749. https:\/\/doi.org\/10.1016\/j.reprotox.2024.108749","journal-title":"Reprod Toxicol"},{"key":"7311_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2024.117352","volume":"288","author":"Y Hong","year":"2024","unstructured":"Hong Y, Wang D, Lin Y et al (2024) Environmental triggers and future risk of developing autoimmune diseases: molecular mechanism and network toxicology analysis of bisphenol A. Ecotoxicol Environ Saf 288:117352. https:\/\/doi.org\/10.1016\/j.ecoenv.2024.117352","journal-title":"Ecotoxicol Environ Saf"},{"key":"7311_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9:559. https:\/\/doi.org\/10.1186\/1471-2105-9-559","journal-title":"BMC Bioinformatics"},{"key":"7311_CR18","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1007\/s10815-024-03155-0","volume":"41","author":"Y Hong","year":"2024","unstructured":"Hong Y, Yuan Q, Wang L et al (2024) Integrative bioinformatics analysis to identify ferroptosis-related genes in non-obstructive azoospermia. J Assist Reprod Genet 41:2145\u20132161. https:\/\/doi.org\/10.1007\/s10815-024-03155-0","journal-title":"J Assist Reprod Genet"},{"key":"7311_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000515","volume":"8","author":"I Samuelsson","year":"2021","unstructured":"Samuelsson I, Parodis I, Gunnarsson I et al (2021) Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case-control study. Lupus Sci Med 8:e000515. https:\/\/doi.org\/10.1136\/lupus-2021-000515","journal-title":"Lupus Sci Med"},{"key":"7311_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/joim.13557","volume":"293","author":"J Frosteg\u00e5rd","year":"2023","unstructured":"Frosteg\u00e5rd J (2023) Systemic lupus erythematosus and cardiovascular disease. J Intern Med 293:48\u201362. https:\/\/doi.org\/10.1111\/joim.13557","journal-title":"J Intern Med"},{"key":"7311_CR21","doi-asserted-by":"publisher","first-page":"9775","DOI":"10.7150\/thno.61677","volume":"11","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Yan X, Zhu H et al (2021) Identification of three tumor antigens and immune subtypes for mRNA vaccine development in diffuse glioma. Theranostics 11:9775\u20139790. https:\/\/doi.org\/10.7150\/thno.61677","journal-title":"Theranostics"},{"key":"7311_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102057","volume":"45","author":"K Toriumi","year":"2021","unstructured":"Toriumi K, Berto S, Koike S et al (2021) Combined glyoxalase 1 dysfunction and vitamin B6 deficiency in a schizophrenia model system causes mitochondrial dysfunction in the prefrontal cortex. Redox Biol 45:102057. https:\/\/doi.org\/10.1016\/j.redox.2021.102057","journal-title":"Redox Biol"},{"key":"7311_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12519-019-00229-3","volume":"16","author":"L Pan","year":"2020","unstructured":"Pan L, Lu MP, Wang JH et al (2020) Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr 16:19\u201330. https:\/\/doi.org\/10.1007\/s12519-019-00229-3","journal-title":"World J Pediatr"},{"key":"7311_CR24","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1001\/jama.2022.23159","volume":"329","author":"F Caravaca-Font\u00e1n","year":"2023","unstructured":"Caravaca-Font\u00e1n F, Yandian F, Fervenza FC (2023) Hydroxychloroquine dose and risk of systemic lupus erythematosus flares. JAMA 329:685\u2013686. https:\/\/doi.org\/10.1001\/jama.2022.23159","journal-title":"JAMA"},{"key":"7311_CR25","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.1093\/rheumatology\/keab347","volume":"60","author":"G Ruiz-Irastorza","year":"2021","unstructured":"Ruiz-Irastorza G (2021) Prednisone in systemic lupus erythematosus: taper quickly, withdraw slowly. Rheumatology (Oxford) 60:5489\u20135490. https:\/\/doi.org\/10.1093\/rheumatology\/keab347","journal-title":"Rheumatology (Oxford)"},{"key":"7311_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20246231","volume":"20","author":"DYH Yap","year":"2019","unstructured":"Yap DYH, Chan TM (2019) B cell abnormalities in systemic lupus erythematosus and lupus nephritis-role in pathogenesis and effect of immunosuppressive treatments. Int J Mol Sci 20:6231. https:\/\/doi.org\/10.3390\/ijms20246231","journal-title":"Int J Mol Sci"},{"key":"7311_CR27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1631\/jzus.B1900607","volume":"21","author":"CY Song","year":"2020","unstructured":"Song CY, Xu YG, Lu YQ (2020) Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects. J Zhejiang Univ Sci B 21:280\u2013290. https:\/\/doi.org\/10.1631\/jzus.B1900607","journal-title":"J Zhejiang Univ Sci B"},{"key":"7311_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.intimp.2019.02.047","volume":"71","author":"X Zhao","year":"2019","unstructured":"Zhao X, Tang X, Yan Q et al (2019) Triptolide ameliorates lupus via the induction of miR-125a-5p mediating Treg upregulation. Int Immunopharmacol 71:14\u201321. https:\/\/doi.org\/10.1016\/j.intimp.2019.02.047","journal-title":"Int Immunopharmacol"},{"key":"7311_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115496","volume":"296","author":"Y Chen","year":"2022","unstructured":"Chen Y, Wang YF, Song SS et al (2022) Potential shared therapeutic and hepatotoxic mechanisms of Tripterygium wilfordii polyglycosides treating three kinds of autoimmune skin diseases by regulating IL-17 signaling pathway and Th17 cell differentiation. J Ethnopharmacol 296:115496. https:\/\/doi.org\/10.1016\/j.jep.2022.115496","journal-title":"J Ethnopharmacol"},{"key":"7311_CR30","first-page":"1234","volume":"28","author":"W Liu","year":"2014","unstructured":"Liu W, Yan L, Zhu Q et al (2014) Therapeutic effect of tripterygium glycosides plus prednisone on moderate active SLE. J Chin Pract Diagn Ther 28:1234\u20131235","journal-title":"J Chin Pract Diagn Ther"},{"key":"7311_CR31","first-page":"159","volume":"113","author":"L Huang","year":"2000","unstructured":"Huang L, Feng S, Wang H (2000) Decreased bone mineral density in female patients with systemic lupus erythematosus after long-term administration of Tripterygium wilfordii Hook. F. Chin Med J (Engl) 113:159\u2013161","journal-title":"Chin Med J (Engl)"},{"key":"7311_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.979307","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Wu Q, Wang Y et al (2022) The molecular pathogenesis of triptolide-induced hepatotoxicity. Front Pharmacol 13:979307. https:\/\/doi.org\/10.3389\/fphar.2022.979307","journal-title":"Front Pharmacol"},{"key":"7311_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107466","volume":"94","author":"X Lu","year":"2021","unstructured":"Lu X, Wang Y, Zhang J et al (2021) Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: a systematic review and meta-analysis. Int Immunopharmacol 94:107466. https:\/\/doi.org\/10.1016\/j.intimp.2021.107466","journal-title":"Int Immunopharmacol"},{"key":"7311_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/bor.0000000000000773","volume":"33","author":"BD Appleton","year":"2021","unstructured":"Appleton BD, Major AS (2021) The latest in systemic lupus erythematosus-accelerated atherosclerosis: related mechanisms inform assessment and therapy. Curr Opin Rheumatol 33:211\u2013218. https:\/\/doi.org\/10.1097\/bor.0000000000000773","journal-title":"Curr Opin Rheumatol"},{"key":"7311_CR35","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/art.24537","volume":"61","author":"AE Hak","year":"2009","unstructured":"Hak AE, Karlson EW, Feskanich D et al (2009) Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses\u2019 health study. Arthritis Rheum 61:1396\u20131402. https:\/\/doi.org\/10.1002\/art.24537","journal-title":"Arthritis Rheum"},{"key":"7311_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107452","volume":"207","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wei W (2020) Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacol Ther 207:107452. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107452","journal-title":"Pharmacol Ther"},{"key":"7311_CR37","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jconrel.2023.04.013","volume":"357","author":"Z Wang","year":"2023","unstructured":"Wang Z, Chen C, Shi C et al (2023) Cell membrane derived liposomes loaded with DNase I target neutrophil extracellular traps which inhibits colorectal cancer liver metastases. J Control Release 357:620\u2013629. https:\/\/doi.org\/10.1016\/j.jconrel.2023.04.013","journal-title":"J Control Release"},{"key":"7311_CR38","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cell.2019.03.046","volume":"177","author":"CX Liu","year":"2019","unstructured":"Liu CX, Li X, Nan F et al (2019) Structure and degradation of circular RNAs regulate PKR Activation in innate immunity. Cell 177:865-880.e821. https:\/\/doi.org\/10.1016\/j.cell.2019.03.046","journal-title":"Cell"},{"key":"7311_CR39","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/art.42391","volume":"75","author":"E Morand","year":"2023","unstructured":"Morand E, Pike M, Merrill JT et al (2023) Deucravacitinib, a tyrosine kinase 2 inhibitor, in systemic lupus erythematosus: a phase II, randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol 75:242\u2013252. https:\/\/doi.org\/10.1002\/art.42391","journal-title":"Arthritis Rheumatol"},{"key":"7311_CR40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41392-022-00948-6","volume":"7","author":"XY Wang","year":"2022","unstructured":"Wang XY, Wei Y, Hu B et al (2022) c-Myc-driven glycolysis polarizes functional regulatory B cells that trigger pathogenic inflammatory responses. Signal Transduct Target Ther 7:105. https:\/\/doi.org\/10.1038\/s41392-022-00948-6","journal-title":"Signal Transduct Target Ther"},{"key":"7311_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01027","volume":"11","author":"J Shan","year":"2020","unstructured":"Shan J, Jin H, Xu Y (2020) T cell metabolism: a new perspective on Th17\/Treg cell imbalance in systemic lupus erythematosus. Front Immunol 11:1027. https:\/\/doi.org\/10.3389\/fimmu.2020.01027","journal-title":"Front Immunol"},{"key":"7311_CR42","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1038\/s41418-021-00775-2","volume":"28","author":"L Yang","year":"2021","unstructured":"Yang L, Li N, Yang D et al (2021) CCL2 regulation of MST1-mTOR-STAT1 signaling axis controls BCR signaling and B-cell differentiation. Cell Death Differ 28:2616\u20132633. https:\/\/doi.org\/10.1038\/s41418-021-00775-2","journal-title":"Cell Death Differ"},{"key":"7311_CR43","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1136\/annrheumdis-2019-215533","volume":"79","author":"Y Wang","year":"2020","unstructured":"Wang Y, Chen S, Chen J et al (2020) Germline genetic patterns underlying familial rheumatoid arthritis, systemic lupus erythematosus and primary Sj\u00f6gren\u2019s syndrome highlight T cell-initiated autoimmunity. Ann Rheum Dis 79:268\u2013275. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215533","journal-title":"Ann Rheum Dis"},{"key":"7311_CR44","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.clim.2011.12.011","volume":"142","author":"A Perl","year":"2012","unstructured":"Perl A (2012) Oxidative stress and endosome recycling are complementary mechanisms reorganizing the T-cell receptor signaling complex in SLE. Clin Immunol 142:219\u2013222. https:\/\/doi.org\/10.1016\/j.clim.2011.12.011","journal-title":"Clin Immunol"},{"key":"7311_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102373","volume":"110","author":"T Suto","year":"2020","unstructured":"Suto T, Karonitsch T (2020) The immunobiology of mTOR in autoimmunity. J Autoimmun 110:102373. https:\/\/doi.org\/10.1016\/j.jaut.2019.102373","journal-title":"J Autoimmun"},{"key":"7311_CR46","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41584-019-0356-x","volume":"16","author":"A Sharabi","year":"2020","unstructured":"Sharabi A, Tsokos GC (2020) T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy. Nat Rev Rheumatol 16:100\u2013112. https:\/\/doi.org\/10.1038\/s41584-019-0356-x","journal-title":"Nat Rev Rheumatol"},{"key":"7311_CR47","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s13238-011-1113-3","volume":"2","author":"Q Meng","year":"2011","unstructured":"Meng Q, Xia Y (2011) c-Jun, at the crossroad of the signaling network. Protein Cell 2:889\u2013898. https:\/\/doi.org\/10.1007\/s13238-011-1113-3","journal-title":"Protein Cell"},{"key":"7311_CR48","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/0092-8674(91)90241-p","volume":"64","author":"WJ Boyle","year":"1991","unstructured":"Boyle WJ, Smeal T, Defize LH et al (1991) Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 64:573\u2013584. https:\/\/doi.org\/10.1016\/0092-8674(91)90241-p","journal-title":"Cell"},{"key":"7311_CR49","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/6854","volume":"21","author":"A Behrens","year":"1999","unstructured":"Behrens A, Sibilia M, Wagner EF (1999) Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet 21:326\u2013329. https:\/\/doi.org\/10.1038\/6854","journal-title":"Nat Genet"},{"key":"7311_CR50","doi-asserted-by":"publisher","first-page":"11833","DOI":"10.1074\/jbc.M111.333997","volume":"287","author":"D Ghosh","year":"2012","unstructured":"Ghosh D, Tsokos GC, Kyttaris VC (2012) c-Jun and Ets2 proteins regulate expression of spleen tyrosine kinase in T cells. J Biol Chem 287:11833\u201311841. https:\/\/doi.org\/10.1074\/jbc.M111.333997","journal-title":"J Biol Chem"},{"key":"7311_CR51","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41423-022-00874-1","volume":"19","author":"R Hisada","year":"2022","unstructured":"Hisada R, Yoshida N, Umeda M et al (2022) The deacetylase SIRT2 contributes to autoimmune disease pathogenesis by modulating IL-17A and IL-2 transcription. Cell Mol Immunol 19:738\u2013750. https:\/\/doi.org\/10.1038\/s41423-022-00874-1","journal-title":"Cell Mol Immunol"},{"key":"7311_CR52","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nri910","volume":"2","author":"Q Li","year":"2002","unstructured":"Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2:725\u2013734. https:\/\/doi.org\/10.1038\/nri910","journal-title":"Nat Rev Immunol"},{"key":"7311_CR53","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jaut.2019.04.018","volume":"102","author":"M Xie","year":"2019","unstructured":"Xie M, Wang J, Gong W et al (2019) NF-\u03baB-driven miR-34a impairs Treg\/Th17 balance via targeting Foxp3. J Autoimmun 102:96\u2013113. https:\/\/doi.org\/10.1016\/j.jaut.2019.04.018","journal-title":"J Autoimmun"},{"key":"7311_CR54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.intimp.2017.03.023","volume":"47","author":"S Gao","year":"2017","unstructured":"Gao S, Yuan L, Li C et al (2017) A novel small molecule compound possesses immunomodulatory properties on bone marrow-derived dendritic cells via TLR7 signaling pathway and alleviates the development of SLE. Int Immunopharmacol 47:47\u201352. https:\/\/doi.org\/10.1016\/j.intimp.2017.03.023","journal-title":"Int Immunopharmacol"},{"key":"7311_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071648","volume":"9","author":"MC Patra","year":"2020","unstructured":"Patra MC, Achek A, Kim GY et al (2020) A novel small-molecule inhibitor of endosomal TLRs reduces inflammation and alleviates autoimmune disease symptoms in murine models. Cells 9:1648. https:\/\/doi.org\/10.3390\/cells9071648","journal-title":"Cells"},{"key":"7311_CR56","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41419-021-04052-5","volume":"12","author":"D Li","year":"2021","unstructured":"Li D, Lu L, Kong W et al (2021) C-type lectin receptor Dectin3 deficiency balances the accumulation and function of FoxO1-mediated LOX-1(+) M-MDSCs in relieving lupus-like symptoms. Cell Death Dis 12:829. https:\/\/doi.org\/10.1038\/s41419-021-04052-5","journal-title":"Cell Death Dis"},{"key":"7311_CR57","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1161\/circimaging.113.000828","volume":"6","author":"K Vandoorne","year":"2013","unstructured":"Vandoorne K, Vandsburger MH, Raz T et al (2013) Chronic Akt1 deficiency attenuates adverse remodeling and enhances angiogenesis after myocardial infarction. Circ Cardiovasc Imaging 6:992\u20131000. https:\/\/doi.org\/10.1161\/circimaging.113.000828","journal-title":"Circ Cardiovasc Imaging"},{"key":"7311_CR58","doi-asserted-by":"publisher","first-page":"e303","DOI":"10.1161\/atvbaha.122.318173","volume":"43","author":"D Jiang","year":"2023","unstructured":"Jiang D, Liu H, Zhu G et al (2023) Endothelial PHACTR1 promotes endothelial activation and atherosclerosis by repressing PPAR\u03b3 activity under disturbed flow in mice. Arterioscler Thromb Vasc Biol 43:e303\u2013e322. https:\/\/doi.org\/10.1161\/atvbaha.122.318173","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7311_CR59","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/s0735-1097(03)00305-x","volume":"41","author":"O Belton","year":"2003","unstructured":"Belton O, Fitzgerald D (2003) Cyclooxygenase-2 inhibitors and atherosclerosis. J Am Coll Cardiol 41:1820\u20131822. https:\/\/doi.org\/10.1016\/s0735-1097(03)00305-x","journal-title":"J Am Coll Cardiol"},{"key":"7311_CR60","doi-asserted-by":"publisher","first-page":"893","DOI":"10.7150\/thno.48080","volume":"11","author":"T Cheng","year":"2021","unstructured":"Cheng T, Ding S, Liu S et al (2021) Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p\/Sirt1\/p53 axis. Theranostics 11:893\u2013905. https:\/\/doi.org\/10.7150\/thno.48080","journal-title":"Theranostics"},{"key":"7311_CR61","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1161\/circresaha.118.312498","volume":"123","author":"AE Kane","year":"2018","unstructured":"Kane AE, Sinclair DA (2018) Sirtuins and NAD(+) in the development and treatment of metabolic and cardiovascular diseases. Circ Res 123:868\u2013885. https:\/\/doi.org\/10.1161\/circresaha.118.312498","journal-title":"Circ Res"},{"key":"7311_CR62","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1161\/circulationaha.114.011675","volume":"130","author":"G Wu","year":"2014","unstructured":"Wu G, Cai J, Han Y et al (2014) LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity. Circulation 130:1452\u20131465. https:\/\/doi.org\/10.1161\/circulationaha.114.011675","journal-title":"Circulation"},{"key":"7311_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.942500","volume":"10","author":"K Riegel","year":"2022","unstructured":"Riegel K, Vijayarangakannan P, Kechagioglou P et al (2022) Recent advances in targeting protein kinases and pseudokinases in cancer biology. Front Cell Dev Biol 10:942500. https:\/\/doi.org\/10.3389\/fcell.2022.942500","journal-title":"Front Cell Dev Biol"},{"key":"7311_CR64","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12943-019-0954-x","volume":"18","author":"J Yang","year":"2019","unstructured":"Yang J, Nie J, Ma X et al (2019) Targeting PI3K in cancer: mechanisms and advances in clinical trials. Mol Cancer 18:26. https:\/\/doi.org\/10.1186\/s12943-019-0954-x","journal-title":"Mol Cancer"},{"key":"7311_CR65","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12943-024-01978-0","volume":"23","author":"X Peng","year":"2024","unstructured":"Peng X, Huang X, Lulu TB et al (2024) A novel pan-PI3K inhibitor KTC1101 synergizes with anti-PD-1 therapy by targeting tumor suppression and immune activation. Mol Cancer 23:54. https:\/\/doi.org\/10.1186\/s12943-024-01978-0","journal-title":"Mol Cancer"},{"key":"7311_CR66","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13045-021-01169-0","volume":"14","author":"J Hu","year":"2021","unstructured":"Hu J, Cao J, Topatana W et al (2021) Targeting mutant p53 for cancer therapy: direct and indirect strategies. J Hematol Oncol 14:157. https:\/\/doi.org\/10.1186\/s13045-021-01169-0","journal-title":"J Hematol Oncol"},{"key":"7311_CR67","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12943-023-01826-7","volume":"22","author":"S Muhammad","year":"2023","unstructured":"Muhammad S, Fan T, Hai Y et al (2023) Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies. Mol Cancer 22:121. https:\/\/doi.org\/10.1186\/s12943-023-01826-7","journal-title":"Mol Cancer"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07311-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07311-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07311-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T10:54:44Z","timestamp":1744455284000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07311-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["7311"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07311-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"11 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}